Doctors' Choice names top journal ads

Share this article:
Doctors' Choice names top journal ads
Doctors' Choice names top journal ads

The Association of Medical Media (AMM) has announced 13 finalists in its The Doctors' Choice awards for best journal ads.

According to the AMM, 5,742 docs reviewed 327 ads, representing the 200 most widely advertised products in 2007. Ad criteria for judging included the “ability to communicate clearly and quickly, help with clinical decisions, prompt seeking more information or re-examining treatment, generate interest, add to information provided by company sales reps and underscore the value of the product prescribed,” according to an AMM statement.

The agencies and their respective clients are:

  • Ferguson, for Roche
  • AbelsonTaylor, for Scios and Takeda
  • Topin & Associates, for Dusa
  • GSW Worldwide, for Lilly
  • MedThink, for Salix
  • Draftfcb Healthcare, for Merck and Boehringer Ingelheim 
  • Harrison and Star, for Genentech
  • Corbett Worldwide, for Alcon
  • Giant, for Actelion

Winners will be announced at a luncheon at The Palace Hotel on Sept. 24, in New York City.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...